Status:
COMPLETED
Low Level Laser Therapy for Autoimmune Thyroiditis
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Autoimmune Thyroiditis
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
INTRODUCTION: Chronic autoimmune thyroiditis (TCA) is the main cause of acquired hypothyroidism, which requires continuous treatment with levothyroxine (LT4). A randomized, placebo-controlled trial in...
Eligibility Criteria
Inclusion
- All patients who have hypothyroidism caused by autoimmune thyroiditis included in the randomized, placebo controlled clinical trial (NCT01129492)
- \-
Exclusion
- All patients who have hypothyroidism caused by autoimmune thyroiditis included in the aforementioned trial (NCT01129492) who underwent surgery and/or therapeutic administration of radioiodine for thyroid diseases during the period between the initial assessment of patients up to the present study.
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT02240563
Start Date
September 1 2014
End Date
March 1 2016
Last Update
May 5 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo General Hospital, Radiology Institute
São Paulo, Brazil, 05403-000
2
University of Sao Paulo General Hospital
São Paulo, Brazil